On Thursday, MoS External Affairs Kirti Vardhan Singh provided a beneficiary-wise breakdown of allocations made available by ...

The statement noted that their efforts would undoubtedly contribute to reducing stigma, increasing awareness and ensuring ...

Gilead stock toppled Thursday on a report CVS won't add the company's new HIV prevention drug, Yeztugo, to its commercial ...

The Gilead HIV prevention shot , called Yevtugo, is highly effective, but its list price is $28, 218 a year in the U.S.

Approved in June for people at high risk of HIV, Yeztugo was shown to be nearly 100% effective at preventing infection in ...

The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...

Couples that were made up of 2 transgender women were less likely to contract HIV compared with couples that were made up of ...

This August, First Baptist Church in Austin hosts a memorial that renders that faith tangible.

California lost funding because the state includes additional content about non-binary gender identity that the Trump administration says is "outside the scope" of the grant's purpose.

Why do people infected with the human immunodeficiency virus (HIV) often suffer from cardiovascular, liver, and other comorbidities? Researchers at the Center for Individualized Infection Medicine ...

The Clark County Health Department says private funds are sustaining some efforts as federal funding and guidance changes.

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...